These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7858104)

  • 41. 5' insulin gene polymorphism confers risk to IDDM independently of HLA class II susceptibility.
    van der Auwera BJ; Heimberg H; Schrevens AF; van Waeyenberge C; Flament J; Schuit FC
    Diabetes; 1993 Jun; 42(6):851-4. PubMed ID: 8495808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-DQB1 typing of north east Italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-enzyme immunoassay (DEIA).
    Tosi G; Mantero G; Magalini AR; Primi D; Soffiati M; Pinelli L; Sartoris S; Tridente G; Accolla RS
    Mol Immunol; 1993 Jan; 30(1):69-76. PubMed ID: 8417376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus.
    Rønningen KS; Iwe T; Halstensen TS; Spurkland A; Thorsby E
    Hum Immunol; 1989 Nov; 26(3):215-25. PubMed ID: 2606746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complementation of HLA-DQA and -DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus.
    Heimberg H; Nagy ZP; Somers G; De Leeuw I; Schuit FC
    Hum Immunol; 1992 Jan; 33(1):10-7. PubMed ID: 1548146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
    Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An investigation of Japanese subjects maps susceptibility to type 1 (insulin-dependent) diabetes mellitus close to the DQA1 gene.
    Jacobs KH; Jenkins D; Mijovic C; Penny M; Uchigata Y; Cavan D; Hirata Y; Otani T; Fletcher J; Barnett AH
    Hum Immunol; 1992 Jan; 33(1):24-8. PubMed ID: 1347765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry.
    Van der Auwera BJ; Vandewalle CL; Schuit FC; Winnock F; De Leeuw IH; Van Imschoot S; Lamberigts G; Gorus FK
    Clin Exp Immunol; 1997 Oct; 110(1):98-103. PubMed ID: 9353155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes.
    Hauache OM; Reis AF; Oliveira CS; Vieira JG; Sjöroos M; Ilonen J
    Dis Markers; 2005; 21(3):139-45. PubMed ID: 16276008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The HLA DQB1*0502 allele is neutrally associated with insulin-dependent diabetes mellitus in the Sardinian population.
    Muntoni F; Congia M; Cucca F; Cossu P; Porcu S; Frau F; Arnone M; Songini M; Muntoni S; Cao A
    Tissue Antigens; 1992 May; 39(5):262-5. PubMed ID: 1412411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
    Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM).
    Yasunaga S; Kimura A; Hamaguchi K; Ronningen KS; Sasazuki T
    Tissue Antigens; 1996 Jan; 47(1):37-48. PubMed ID: 8929711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients.
    Kwon OJ; Brautbar C; Weintrob N; Sprecher E; Saphirman C; Bloch K; Pinhas-Hamiel O; Assah S; Vardi P; Israel S
    Hum Immunol; 2001 Jan; 62(1):85-91. PubMed ID: 11165718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-DRB1 and DQB1 genotypes in patients with insulin-dependent neonatal diabetes mellitus. A study of 13 cases.
    Marquis E; Le Monnier de Gouville I; Bouvattier C; Robert JJ; Junien C; Charron D; Hors J; Diatloff-Zito C
    Tissue Antigens; 2000 Sep; 56(3):217-22. PubMed ID: 11034557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes.
    Hoover ML; Marta RT
    Scand J Immunol; 1997 Feb; 45(2):193-202. PubMed ID: 9042432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus.
    Esposito L; Lampasona V; Bosi E; Poli F; Ferrari M; Bonifacio E
    Diabetologia; 1995 Aug; 38(8):968-74. PubMed ID: 7589884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of insulin-dependent diabetes mellitus (IDDM)-related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region.
    Nejentsev S; Koskinen S; Sjöroos M; Reijonen H; Schwartz EI; Kovalchuk L; Sochnev A; Adojaan B; Podar T; Knip M; Simell O; Koskenvuo M; Akerblom HK; Ilonen J
    Tissue Antigens; 1998 Nov; 52(5):473-7. PubMed ID: 9864037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of genetic risk load defined by HLA-DQB1 polymorphism on clinical characteristics of IDDM in children.
    Veijola R; Knip M; Reijonen H; Vähäsalo P; Puukka R; Iionen J
    Eur J Clin Invest; 1995 Feb; 25(2):106-12. PubMed ID: 7737259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM.
    Pugliese A; Gianani R; Moromisato R; Awdeh ZL; Alper CA; Erlich HA; Jackson RA; Eisenbarth GS
    Diabetes; 1995 Jun; 44(6):608-13. PubMed ID: 7789622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The combination of several polymorphic amino acid residues in the DQalpha and DQbeta chains forms a domain structure pattern and is associated with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Landin-Olsson M; Kockum I; Dahlquist G; Lernmark A
    Ann N Y Acad Sci; 2002 Apr; 958():362-75. PubMed ID: 12021143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes.
    Erlich HA; Griffith RL; Bugawan TL; Ziegler R; Alper C; Eisenbarth G
    Diabetes; 1991 Apr; 40(4):478-81. PubMed ID: 2010048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.